Freestone Capital Holdings’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-258,421
| Closed | -$5.57M | – | 445 |
|
|
2018
Q3 | $5.57M | Sell |
258,421
-7,293
| -3% | -$157K | 0.04% | 80 |
|
|
2018
Q2 | $6.46M | Buy |
265,714
+23,410
| +10% | +$569K | 0.04% | 69 |
|
|
2018
Q1 | $4.14M | Buy |
242,304
+129,176
| +114% | +$2.21M | 0.24% | 103 |
|
|
2017
Q4 | $2.14M | Sell |
113,128
-32,584
| -22% | -$618K | 0.15% | 145 |
|
|
2017
Q3 | $2.57M | Buy |
145,712
+37,583
| +35% | +$662K | 0.18% | 129 |
|
|
2017
Q2 | $3.59M | Buy |
108,129
+16,899
| +19% | +$561K | 0.28% | 98 |
|
|
2017
Q1 | $2.93M | Buy |
91,230
+48,403
| +113% | +$1.55M | 0.23% | 120 |
|
|
2016
Q4 | $1.55M | Sell |
42,827
-53,945
| -56% | -$1.95M | 0.13% | 152 |
|
|
2016
Q3 | $4.45M | Buy |
96,772
+11,341
| +13% | +$522K | 0.41% | 50 |
|
|
2016
Q2 | $4.29M | Buy |
85,431
+17,624
| +26% | +$885K | 0.42% | 49 |
|
|
2016
Q1 | $3.63M | Buy |
67,807
+14,387
| +27% | +$770K | 0.38% | 48 |
|
|
2015
Q4 | $3.51M | Buy |
53,420
+14,978
| +39% | +$983K | 0.36% | 43 |
|
|
2015
Q3 | $2.17M | Buy |
38,442
+25,201
| +190% | +$1.42M | 0.24% | 63 |
|
|
2015
Q2 | $783K | Buy |
+13,241
| New | +$783K | 0.12% | 127 |
|
|
2014
Q2 | – | Sell |
-6,904
| Closed | -$365K | – | 244 |
|
|
2014
Q1 | $365K | Sell |
6,904
-6,229
| -47% | -$329K | 0.06% | 146 |
|
|
2013
Q4 | $527K | Buy |
13,133
+5,088
| +63% | +$204K | 0.09% | 182 |
|
|
2013
Q3 | $304K | Sell |
8,045
-337
| -4% | -$12.7K | 0.05% | 269 |
|
|
2013
Q2 | $329K | Buy |
+8,382
| New | +$329K | 0.07% | 234 |
|